Xutao, Guo <br/><br/>
BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy.  [electronic resource] 

 -  Pharmacogenomics  03 2018 
 - 343-348 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-8042 
<br/><br/><label>Standard No.: </label>10.2217/pgs-2017-0157  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--genetics<br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Carrier Proteins--genetics<br/>Female<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Nuclear Proteins--genetics<br/>Prognosis<br/>Remission Induction--methods<br/>Repressor Proteins